Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
about
Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsThe Saudi Initiative for Asthma.Inhaled CorticosteroidsThymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised careThe Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Sleep disorders in patients with bronchial asthma.Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Fluticasone furoate and vilanterol trifenatate combination therapy for the treatment of asthma.Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
P2860
Q26747066-BEFD866A-100B-4378-9172-17165ADBE853Q33568644-FB99E472-ADCC-4865-9EF2-5F1B71458603Q33664193-7D94EDC7-4E75-4ADE-890E-494C97BDD2F4Q35173486-A71485A4-0D5E-443A-B16B-4FB4FE6F9195Q35538249-E59B3888-BA55-458C-AFDD-86E56DAA1640Q35779621-38A12351-DE78-4E67-B088-6C77489B4FFEQ36422663-F41432BF-A69E-45BB-9804-23F2710C62B7Q36566081-01886ADF-344A-459B-99BB-9261A8B396F7Q36787327-4DCBAA27-23D8-4AA5-B072-B72B3FC8E792Q38904485-5267D682-3249-4876-AAB8-534DD0B42CA1Q38947467-374FAB8A-D21F-4741-A34F-6098C8866255Q40661319-C6757E21-B04C-45AF-80A0-1B67CB30F116Q44765635-8DC60480-2540-45A0-B3D1-722AF003B240Q46528029-63D6E589-4213-44DF-8F0D-78B5D11EE5A2
P2860
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Add-on therapy options in asth ...... eroids: a comprehensive review
@ast
Add-on therapy options in asth ...... eroids: a comprehensive review
@en
Add-on therapy options in asth ...... eroids: a comprehensive review
@nl
type
label
Add-on therapy options in asth ...... eroids: a comprehensive review
@ast
Add-on therapy options in asth ...... eroids: a comprehensive review
@en
Add-on therapy options in asth ...... eroids: a comprehensive review
@nl
prefLabel
Add-on therapy options in asth ...... eroids: a comprehensive review
@ast
Add-on therapy options in asth ...... eroids: a comprehensive review
@en
Add-on therapy options in asth ...... eroids: a comprehensive review
@nl
P2093
P2860
P31
P3181
P356
P1433
P1476
Add-on therapy options in asth ...... eroids: a comprehensive review
@en
P2093
Aarne Lahdensuo
Eeva Moilanen
Peter J Barnes
P2860
P2888
P3181
P356
10.1186/1465-9921-5-17
P407
P577
2004-01-01T00:00:00Z
2004-10-27T00:00:00Z
P5875
P6179
1039385873